Page last updated: 2024-09-03

pyroglutamyl-glutamyl-proline amide and Cancer of Pituitary

pyroglutamyl-glutamyl-proline amide has been researched along with Cancer of Pituitary in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
de Greef, WJ; de Herder, WW; de Jong, FH; Klootwijk, W; Lambalk, CB; Sleddens-Linkels, E; Visser, TJ1

Other Studies

1 other study(ies) available for pyroglutamyl-glutamyl-proline amide and Cancer of Pituitary

ArticleYear
Evidence that the TRH-like peptide pyroglutamyl-glutamyl-prolineamide in human serum may not be secreted by the pituitary gland.
    The Journal of endocrinology, 1997, Volume: 155, Issue:2

    Topics: Adult; Aged; Chromatography, High Pressure Liquid; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Immunoradiometric Assay; Luteinizing Hormone; Male; Menstruation; Middle Aged; Obesity; Petrosal Sinus Sampling; Pituitary Gland; Pituitary Neoplasms; Postmenopause; Pyrrolidonecarboxylic Acid; Radioimmunoassay; Thyrotropin-Releasing Hormone

1997